Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. - Wikidata - awgldk - TriplyDB

Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.

Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.

http://www.wikidata.org/entity/Q44114915

about

Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm Clinical significance of procoagulant microparticles Role of plasma kallikrein in diabetes and metabolism Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review Preeclampsia and Extracellular Vesicles Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions.Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation Endothelial Extracellular Vesicles-Promises and Challenges CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea.Circulating endothelial microparticles in diabetes mellitus Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia.Circulating CD62E+ microparticles and cardiovascular outcomes.Endothelial progenitor cells as factors in neovascularization and endothelial repair Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes.ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology.Platelets, atherosclerosis and the endothelium: new therapeutic targets?Simultaneous Enrichment of Plasma Soluble and Extracellular Vesicular Glycoproteins Using Prolonged Ultracentrifugation-Electrostatic Repulsion-hydrophilic Interaction Chromatography (PUC-ERLIC) Approach.Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles.Pathological impairments induced by interstitial implantation of 125I seeds in spinal canal of banna mini-pigs Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation.Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies.Microvesicles/exosomes as potential novel biomarkers of metabolic diseases Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders.Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.Protection against cerebral malaria by the low-molecular-weight thiol pantethine.Clinical and therapeutical implications of EPC biology in atherosclerosis.Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.Microvesicles as potential ovarian cancer biomarkers.The origin of circulating CD36 in type 2 diabetes.Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Endothelial progenitor cells in health and atherosclerotic disease.

P2860

Q26768704-2C06E6E1-A002-4E43-BA2C-74A1C1C92F7A Q26830846-8F4AF78B-5385-4A75-8930-F78108EA130C Q27016431-CF9C024A-F0E3-468E-9F15-7805E3831ECB Q28069254-9DF502D3-6BC1-4020-85A9-2AFDC668EB8F Q28071774-2317BD6E-5623-467D-BBC4-B03FA2355045 Q28079349-C7A6DFF7-0D83-4B12-B049-2F0D9737BC77 Q28386977-9674E967-7486-4598-8E01-2EFB4EEE0CCC Q31137300-52D54F98-86D7-47D0-B6E2-1FA51FF790D4 Q33401969-86AA3235-8BC6-40E9-8FBE-2FB37CCFC789 Q33518352-98160400-1245-4B89-91BF-1F94951E793B Q33639065-9F019814-ECE3-4203-A155-B0D3FAA66015 Q33690900-31FE0036-5FE7-44FD-9E1E-821B49A73C9E Q33916623-E4C29EE6-8259-4F52-9C80-D14EA0395F77 Q33953737-86A5D3CD-FBE9-4D15-975F-F4B1F35EE430 Q33996570-502DA01F-F0FF-4996-8A55-9B843B256EF6 Q34026858-32CF124A-E92D-44C5-9250-3F622D173B9A Q34080036-C70CF860-1385-4679-8F79-C12AE7938044 Q34238659-DE732FD6-88EA-4033-9791-B19772C0335D Q34259709-94CE5614-38A6-4AC4-BE17-8C37AC8B461C Q34444790-EC016BD1-753C-4CE2-8F54-AAC93A123717 Q34469009-65F194A3-F1D1-478C-9120-56D1CB1CFE90 Q34792852-8F93FD3C-CBB6-4260-85F4-5FA13B5C6378 Q35083516-DF172D47-4CA8-4AD8-B966-6E2DCAF2CF06 Q35570940-D1DCA7CD-4B62-4016-86CD-A77FB261B0E1 Q35692136-91121558-CB33-40E6-A68A-BAF94FB01CC9 Q35850777-9122D2A1-D81B-487E-A4A9-38485972BFB3 Q35854282-06A68258-05A1-4FCF-A890-803315710B06 Q35934133-B8CA89CB-40C1-43D3-89F9-01442D915575 Q36035053-27ABB8A2-FB61-4581-8F69-B63EB9EABA79 Q36144112-E59FFBBB-2D5E-4B50-A252-8A9C75B44D8A Q36175435-106FDCF7-E2D7-4C03-8BF8-3B4DFDD27F3F Q36232987-61CEEA61-5DE7-4B15-B90F-8A4A94B320CD Q36443389-25C234CF-7365-4CB4-9EF3-04B93E6A7F96 Q36446215-4D674B97-B39C-4DFC-9EDA-401B42642FB6 Q36517055-D893C194-9F1D-4A1E-B0B5-A9F5E8EEB7FF Q36580760-3DF11F57-4AE4-4043-9F4B-D94908C980C4 Q36635032-0A645D09-412B-46CA-9E9B-E66EE71EA402 Q36647084-CA953FBF-41DE-4C77-93CA-A5D3AE6984DE Q36745194-1A1EFBA8-C9FD-417D-AD92-B15FE0BD624A Q36799382-365DD1DC-CCCD-4F19-8220-1FC292029975

P2860

Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.

http://www.wikidata.org/entity/Q44114915

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Type 1 and type 2 diabetic pat ...... ns of cellular microparticles.

@en

Type 1 and type 2 diabetic pat ...... ns of cellular microparticles.

@nl

type

label

Type 1 and type 2 diabetic pat ...... ns of cellular microparticles.

@en

Type 1 and type 2 diabetic pat ...... ns of cellular microparticles.

@nl

prefLabel

Type 1 and type 2 diabetic pat ...... ns of cellular microparticles.

@en

Type 1 and type 2 diabetic pat ...... ns of cellular microparticles.

@nl

P1433

Q44114915-BDED6472-BA77-49D9-82C9-2E5FC2D8104F

P1476

Q44114915-A1371F92-5B64-4894-8578-42F3A056A058

P2093

Q44114915-006292C1-3E6F-4FC7-9712-802C9A36D4B2

Q44114915-0677EDE1-3AD1-4F17-B8E2-B0927411296D

Q44114915-0FF96B55-A438-4603-8D31-3CFF0CCA2CCD

Q44114915-44A976C0-FBF8-494E-96BE-2DD0B22FBF53

Q44114915-68CF98B5-BAD6-49CC-8FC9-8D6360E0345D

Q44114915-712756B0-5C4D-48E1-97CA-5477B4B7EC67

Q44114915-7CA51F51-E3BC-43B1-9D24-76F7A7889FB0

Q44114915-9E77DF50-16E6-4657-84F0-0CD2DA5AF1A3

Q44114915-B68AA0AE-0E2B-4199-8328-456C9B2D5807

Q44114915-C5CF24B9-CF9F-49D2-8749-2043516B9095

P304

Q44114915-47949CC1-4D44-4B8D-A63D-FB188A6F4C73

P31

Q44114915-9985777A-3958-425D-9644-B8778F6B0152

P356

Q44114915-1CCE2DFD-B003-4D89-A593-EBC4651FCF3A

P407

Q44114915-C4354134-F6A2-42D8-A2A6-CBC62E2D600F

P433

Q44114915-0C56AFE4-B554-4A5A-B647-DBF089164F79

P478

Q44114915-BA628F33-A678-4ADD-8896-63D51FE5ACDB

P577

Q44114915-3C10EFAD-32C6-4641-8D7F-4AB8F1996587

P5875

Q44114915-AF3C15A5-4052-4898-BA54-F712E973FFC9

P698

Q44114915-C88CA486-D384-4FBF-B3B8-175A49669AE8

P921

Q44114915-702ADE99-FD33-4368-A1FC-6D255130ABD9

P356

DIABETES.51.9.2840

P1433

P1476

Type 1 and type 2 diabetic pat ...... ns of cellular microparticles.

@en

P2093

Benedicte Hugel

http://www.w3.org/2001/XMLSchema#string

Charles Oliver

http://www.w3.org/2001/XMLSchema#string

Dominique Arnoux

http://www.w3.org/2001/XMLSchema#string

Florence Sabatier

http://www.w3.org/2001/XMLSchema#string

Francoise Dignat-George

http://www.w3.org/2001/XMLSchema#string

Jean-Gabriel Velut

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Freyssinet

http://www.w3.org/2001/XMLSchema#string

Jose Sampol

http://www.w3.org/2001/XMLSchema#string

Marielle Sanmarco

http://www.w3.org/2001/XMLSchema#string

Patrice Darmon

http://www.w3.org/2001/XMLSchema#string

P304

2840-2845

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIABETES.51.9.2840

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11192757

http://www.w3.org/2001/XMLSchema#string

P698

12196479

http://www.w3.org/2001/XMLSchema#string

P921